Anika Therapeutics (ANIK) P/FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | 158.6 | 0.00 | 0.00 | -104.0 | 31.6 | 188.6 | |||
| Changes by years, y/y, % | +182% | -100% | -130% | -10.9% | |||||
Anika Therapeutics. P/FCF
Anika Therapeutics. P/FCF, changes, %
Anika Therapeutics (ANIK) P/FCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/FCF | -54.4 | -133.9 | 209.2 | 31.4 | 188.8 | 188.6 | ||
| Changes by years, y/y, % | -181% | -138% | -447% | |||||
| Changes by quarters, q/q, % | -34% | +146% | -256% | -85% | +501% | |||